Accessibility StatementSkip Navigation NEW YORK, Nov. 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Avantor, Inc. ("Avantor, Inc." or the "Company") (NYSE: AVTR) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Avantor, Inc. investors who were adversely affected by alleged securities fraud between March 5, 2024 and October 28, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zl ...

BOSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Berman Tabacco, a national law firm representing investors, announces its investigation into potential stockholder claims involving SelectQuote, Inc. (“SelectQuote”) (NYSE:SLQT) allegedly receiving illegal payments from health insurance providers. About the Investigation Allegations that SelectQuote received illegal payments and other claims were unsealed in May 2025 after the U.S. Attorney’s Office for the District of Massachusetts intervened to join claims pendin ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against StubHub Holdings, Inc. following a significant drop in its stock price, which closed at approximately $14.87, reflecting a 20.9% decline in a single day [2][4]. Company Overview - StubHub Holdings, Inc. priced its IPO at $23.50 per share on September 18, 2025, with shares initially rising to a peak of $27.89 shortly after listing [3]. - By October 10, 2025, the stock had fallen to $18.89, representing a 19.7% decline from the IPO price [3]. Financial Performance - The company reported first-quarter earnings on November 13, 2025, with revenue of approximately $468 million, marking an 8% year-over-year increase [3]. - Despite the better-than-expected revenue, management did not provide forward guidance for the current quarter or full year, citing unpredictability in ticket on-sale timing [4]. Stock Performance - Following the lack of guidance, StubHub's shares experienced a sharp decline, closing at around $14.87 on November 14, 2025, which was a significant drop of 20.9% in one day [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Freeport-McMoran Inc. due to allegations of violations of federal securities laws related to safety issues at the Grasberg Block Cave mine in Indonesia, which resulted in significant investor losses [4][6]. Group 1: Allegations and Legal Actions - The complaint alleges that Freeport and its executives made false and misleading statements regarding safety at the Grasberg Block Cave mine, failing to disclose risks that could foreseeably lead to worker fatalities [6]. - Investors who purchased Freeport securities between February 15, 2022, and September 24, 2025, are encouraged to discuss their legal rights with the firm, with a deadline of January 12, 2026, to seek the role of lead plaintiff in the class action [4][11]. Group 2: Incident Details and Stock Impact - On September 9, 2025, Freeport suspended mining activities at the Grasberg mine after an incident trapped seven workers, leading to a stock price drop of $2.77, or 5.9%, closing at $43.89 per share [7]. - Following the tragic update on September 24, 2025, that two workers were fatally injured, Freeport's stock fell by $7.69, or 17%, to close at $37.67 per share [8]. - An article published on September 25, 2025, highlighted potential strains in Freeport's relationship with the Indonesian government due to the halt in production, resulting in a further stock decline of $2.33, or 6.2%, to close at $35.34 [9][10].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Stride, Inc. due to allegations of securities law violations, urging affected investors to contact them before the January 12, 2026 deadline for lead plaintiff applications in a federal class action lawsuit [2][5]. Group 1: Allegations Against Stride, Inc. - The complaint alleges that Stride and its executives made false or misleading statements and failed to disclose critical information regarding their products and services to educational institutions [5]. - Stride is accused of inflating enrollment numbers, cutting staff costs excessively, ignoring compliance requirements, and losing both existing and potential enrollments [5]. - A report indicated that the Gallup-McKinley County Schools Board of Education filed a complaint against Stride for fraud and deceptive practices, including retaining "ghost students" to secure state funding [6]. Group 2: Stock Price Impact - Following the allegations, Stride's stock price dropped by $18.60, or 11.7%, closing at $139.76 per share on September 15, 2025, impacting investors negatively [7]. - On October 28, 2025, Stride reported a limitation in enrollment growth and issues with system implementation, leading to a significant drop in enrollments by approximately 10,000 to 15,000 [8]. - The stock price fell as much as 51% during intraday trading on October 29, 2025, further injuring investors [8].

Core Insights - Ardent Health, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws [1] - The company reported a $43 million reduction in revenue and a $54 million increase in professional liability reserves in its Q3 2025 financial results [2] - Following the announcement, Ardent's stock experienced a significant decline during pre-market trading [3] Financial Performance - Ardent Health disclosed a $43 million decrease in revenue due to changes in accounting estimates related to accounts receivable [2] - The company also reported a $54 million increase in professional liability reserves for claims in New Mexico [2] Market Reaction - The announcement of the financial results led to a notable drop in Ardent's common stock during pre-market trading on November 13, 2025 [3]

New York, New York--(Newsfile Corp. - November 18, 2025) - If you suffered a loss on your Firefly Aerospace Inc. (NASDAQ: FLY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/firefly-aerospace-inc-lawsuit-submission-form?prid=178000&wire=5&utm_campaign=2or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212) 363-7500 to speak to our team of experienced shareholder advocat ...

Core Viewpoint - A lawsuit has been filed against Firefly Aerospace Inc. alleging that the company made false statements regarding its business prospects and operational readiness, which may have led to financial losses for investors [2][3]. Group 1: Lawsuit Details - The lawsuit represents a class of individuals and entities that purchased Firefly common stock during its initial public offering on August 7, 2025, and those who acquired securities between August 7, 2025, and September 29, 2025 [2]. - The complaint claims that Firefly overstated demand and growth prospects for its Spacecraft Solutions offerings and the operational readiness of its Alpha rocket program, which could have a material negative impact on the company [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Firefly Aerospace Inc. stock during the specified timeframe are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP is highlighted as a nationally-recognized securities litigation firm with a strong track record in securing recoveries for shareholders, having ranked in the Top 50 Report for seven consecutive years [5].

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In The Wildermuth Fund To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired in The Wildermuth Fund between November 1, 2020 and June 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - Nov ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Baxter International Inc. due to allegations of false and misleading statements regarding the Novum LVP medical device, which has been linked to serious malfunctions and patient risks [2][5]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Baxter between February 23, 2022, and July 30, 2025, to discuss their legal rights [1]. - A federal securities class action has been filed against Baxter, with a deadline of December 15, 2025, for investors to seek the role of lead plaintiff [2]. Group 2: Allegations Against Baxter - The complaint alleges that Baxter and its executives violated federal securities laws by failing to disclose systemic defects in the Novum LVP, which caused malfunctions that could lead to serious injury or death [5]. - Baxter was reportedly aware of multiple device malfunctions and injuries but did not take adequate remedial measures, leading to a heightened risk of product withdrawal from the market [5]. Group 3: Stock Impact - The extent of the alleged fraud was revealed on July 31, 2025, when Baxter announced a voluntary pause in shipments and installations of the Novum LVP, resulting in a 22.4% drop in stock price, closing at $21.76 [6].